Literature DB >> 12692556

The p75 receptor acts as a displacement factor that releases Rho from Rho-GDI.

Toshihide Yamashita1, Masaya Tohyama.   

Abstract

The neurotrophin receptor p75(NTR) is involved in the regulation of axonal elongation by neurotrophins as well as several myelin components, including Nogo, myelin-associated glycoprotein (MAG) and myelin oligodendrocyte glycoprotein (OMgp). Neurotrophins stimulate neurite outgrowth by inhibiting Rho activity, whereas myelin-derived proteins activate RhoA and thereby inhibit growth. Here we show that direct interaction of the Rho GDP dissociation inhibitor (Rho-GDI) with p75(NTR) initiates the activation of RhoA, and this interaction between p75(NTR) and Rho-GDI is strengthened by MAG or Nogo. We also found that p75(NTR) facilitates the release of prenylated RhoA from Rho-GDI. The peptide ligand that is associated with the fifth alpha helix of p75(NTR) inhibits the interaction between Rho-GDI and p75(NTR), thus silencing the action mediated by p75(NTR). This peptide has potential as a therapeutic agent against the inhibitory cues that block regeneration in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12692556     DOI: 10.1038/nn1045

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  171 in total

1.  Ameliorative Effects of p75NTR-ED-Fc on Axonal Regeneration and Functional Recovery in Spinal Cord-Injured Rats.

Authors:  Yong-Tang Wang; Xiu-Min Lu; Feng Zhu; Peng Huang; Ying Yu; Zai-Yun Long; Ya-Min Wu
Journal:  Mol Neurobiol       Date:  2014-11-15       Impact factor: 5.590

2.  Autoantobodies activate small GTPase RhoA to modulate neurite outgrowth.

Authors:  Kazim A Sheikh
Journal:  Small GTPases       Date:  2011-07-01

3.  Fibroblast growth factor-inducible-14 is induced in axotomized neurons and promotes neurite outgrowth.

Authors:  Katsuhisa Tanabe; Iris Bonilla; Jeffrey A Winkles; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2003-10-22       Impact factor: 6.167

4.  Switching mature retinal ganglion cells to a robust growth state in vivo: gene expression and synergy with RhoA inactivation.

Authors:  Dietmar Fischer; Victoria Petkova; Solon Thanos; Larry I Benowitz
Journal:  J Neurosci       Date:  2004-10-06       Impact factor: 6.167

5.  Quantitative analysis of prenylated RhoA interaction with its chaperone, RhoGDI.

Authors:  Zakir Tnimov; Zhong Guo; Yann Gambin; Uyen T T Nguyen; Yao-Wen Wu; Daniel Abankwa; Anouk Stigter; Brett M Collins; Herbert Waldmann; Roger S Goody; Kirill Alexandrov
Journal:  J Biol Chem       Date:  2012-05-24       Impact factor: 5.157

Review 6.  Neural regeneration: lessons from regenerating and non-regenerating systems.

Authors:  Leonardo M R Ferreira; Elisa M Floriddia; Giorgia Quadrato; Simone Di Giovanni
Journal:  Mol Neurobiol       Date:  2012-06-21       Impact factor: 5.590

7.  Myelin-associated glycoprotein (MAG) protects neurons from acute toxicity using a ganglioside-dependent mechanism.

Authors:  Niraj R Mehta; Thien Nguyen; John W Bullen; John W Griffin; Ronald L Schnaar
Journal:  ACS Chem Neurosci       Date:  2010-03-17       Impact factor: 4.418

Review 8.  New Insights into the Roles of Nogo-A in CNS Biology and Diseases.

Authors:  Yun-Peng Sui; Xiao-Xi Zhang; Jun-Lin Lu; Feng Sui
Journal:  Neurochem Res       Date:  2015-08-13       Impact factor: 3.996

9.  RhoGDIbeta lacking the N-terminal regulatory domain suppresses metastasis by promoting anoikis in v-src-transformed cells.

Authors:  Takahide Ota; Masayo Maeda; Shiho Sakita-Suto; Xinwen Zhou; Manabu Murakami; Tsutomu Takegami; Masaaki Tatsuka
Journal:  Clin Exp Metastasis       Date:  2006-11-17       Impact factor: 5.150

10.  Merlin isoform 2 in neurofibromatosis type 2-associated polyneuropathy.

Authors:  Alexander Schulz; Stephan L Baader; Michiko Niwa-Kawakita; Marie Juliane Jung; Reinhard Bauer; Cynthia Garcia; Ansgar Zoch; Stephan Schacke; Christian Hagel; Victor-Felix Mautner; C Oliver Hanemann; Xin-Peng Dun; David B Parkinson; Joachim Weis; J Michael Schröder; David H Gutmann; Marco Giovannini; Helen Morrison
Journal:  Nat Neurosci       Date:  2013-03-03       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.